Medicare AdvantageCoverageMedium impact
Hyperbaric Oxygen Therapy, Topical Oxygen Therapy - Medicare Advantage (Revised)
Humana·Wound Care, Infectious Disease, Vascular Surgery +2 more·Medicare Advantage
Effective date
Jun 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has revised their policy for Hyperbaric Oxygen Therapy (HBOT) and Topical Oxygen Therapy, providing updated coverage criteria and treatment recommendations for specific conditions including osteomyelitis, carbon monoxide poisoning, and crush injuries. The policy establishes specific session limits and clinical requirements for each covered indication.
Action Required
Before June 1, 2026: Review current HBOT billing practices and ensure documentation meets the updated coverage criteria for each indication. Update prior authorization requests to include specific clinical requirements outlined in the policy (bone culture confirmation for osteomyelitis, vascular studies for arterial insufficiency, etc.). Train clinical staff on the recommended session limits for each condition to avoid claim denials.